Related Experiment Videos
Tumour stimulation by anti-oestrogens
The British Journal of Surgery
|December 1, 1977
Abstract:
Two women who developed tumour progression while taking anti-oestrogens are described and some of the possible mechanisms for this action are discussed.
Insights
Tumour progression occurred in two women despite anti-oestrogen therapy. This case study explores potential mechanisms behind treatment resistance to anti-oestrogen medications.
Area of Science:
- Oncology
- Pharmacology
Background:
- Anti-oestrogen therapies are standard treatments for hormone-receptor-positive breast cancer.
- Tumour resistance to anti-oestrogens can limit treatment efficacy.
Observation:
- Two cases of women experiencing tumour progression while on anti-oestrogen therapy were documented.
- Clinical data and treatment histories were reviewed for these patients.
Findings:
- The study discusses potential biological mechanisms contributing to anti-oestrogen resistance.
- Possible mechanisms include alterations in oestrogen receptor (ER) signalling or activation of alternative growth pathways.
Implications:
- Understanding these mechanisms is crucial for developing strategies to overcome anti-oestrogen resistance.
- Further research into resistance pathways may lead to improved therapeutic options for breast cancer patients.